Work

Smoking Interacts With CHRNA5, a Nicotinic Acetylcholine Receptor Subunit Gene, to Influence the Risk of IBD-Related Surgery

Year: 2018

Type: article

Abstract: Background: Inflammatory bowel disease (IBD) is a chronic luminal disease with genetic and environmental factors affecting phenotype.This study evaluated the relationship between CHRNA5, a nicotinic receptor subunit gene, and smoking in predicting IBD-related surgery as well as the relationship between CHRNA5 and nicotine dependence.Methods: Participants completed a smoking questionnaire and were genotyped for CHRNA5 rs16969968.Demographic and clinical data were obtained from medical records.Wilcoxon, ANOVA, Chi square, and Fisher's exact tests were used for comparisons.Logistic regression was used to evaluate the effect of clinical and genetic predictors on surgery, stratified by disease subtype given paradoxical effects of smoking.Kaplan-Meier curves were used to examine the effect of smoking and genotype on time to surgery.(Significance: P < 0.05 for main effects; P < 0.2 for interaction terms) Results: 400 (65.8%) patients had Crohn's disease (CD) and 208 (34.2%) had ulcerative colitis (UC).298 (49%) underwent an IBD-related surgery.There was a trend towards significance between rs16969968 and smoking behavior (smoking status [P = 0.05], nicotine dependence [AA > AG > GG; P = 0.08]).Smoking and genotype were not independently associated with surgery in UC or CD.However, interaction between rs16969968 and smoking in predicting surgery was observed for both UC (OR = 2.72; P = 0.05) and CD (OR = 2.88; P = 0.1).CHRNA5 genotype, but not smoking, predicted time to surgery in patients with UC (P = 0.007) but not in patients with CD.The interaction between smoking and genotype was not significantly associated with time to surgery in UC or CD. Conclusions:The CHRNA5 rs16969968 A variant interacts with smoking to influence IBD-related surgery.

Source: Inflammatory Bowel Diseases

DOI: 10.1093/ibd/izx094